Yahoo Finance

Operations: Synairgen plc does not report any revenue segments.

Market Cap: £4.23M

Synairgen plc, with a market cap of £4.23 million, operates in the biotech sector focusing on respiratory disease treatments. The company is pre-revenue and currently unprofitable, with no significant lines of revenue reported. Despite this, Synairgen has a solid cash position to cover short-term liabilities (£10.5M in assets against £1.1M liabilities) and remains debt-free. Recent capital raising through a follow-on equity offering of £24 million suggests efforts to extend its cash runway beyond 12 months amid high share price volatility and an inexperienced board averaging 2.3 years tenure, contrasting with an experienced management team (3.7 years).

• Jump into the full analysis health report here for a deeper understanding of Synairgen.

• Gain insights into Synairgen's outlook and expected performance with our report on the company's earnings estimates.

Lift Global Ventures

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Lift Global Ventures Plc is a UK-based financial public relations and investor relations consulting company with a market cap of £334,985.

Operations: The company generates revenue primarily from its Financial PR Services segment, totaling £0.48 million.

Market Cap: £334.99k

Lift Global Ventures Plc, with a market cap of £334,985, is pre-revenue and unprofitable, generating £477K in revenue from its Financial PR Services segment. The company maintains a solid cash runway exceeding three years without debt or long-term liabilities. Despite declining revenue by 1.6% over the past year and increased net loss to £986K for the year ended June 2024, Lift's short-term assets (£261.3K) comfortably cover its short-term liabilities (£120.3K). The board's average tenure of 2.1 years indicates inexperience while volatility has decreased significantly from 17% to 4%.

• Take a closer look at Lift Global Ventures' potential here in our financial health report.

• Understand Lift Global Ventures' track record by examining our performance history report.

Make It Happen

• Embark on your investment journey to our 463 UK Penny Stocks selection here.

• Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.

• Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Seeking Other Investments?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Jump on the AI train with fast growing tech companies forging a new era of innovation.

• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include AIM:ESYS AIM:SNG and OFEX:LFT.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com